Northwest Biotherapeutics (QB) Stock Price

0.00535 (1.53%)
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Northwest Biotherapeutics Inc (QB) NWBO OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.00535 1.53% 0.35435 0.3475 0.36 0.35 0.349 16:35:04
Bid Price Ask Price Spread Spread % News
0.32 0.37 0.05 13.51% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
244 1,160,072 $ 0.353219 $ 409,759 2,571,324 0.14 - 0.419
Last Trade Time Type Quantity Stock Price Currency
15:59:57 400 $ 0.35435 USD

Northwest Biotherapeutics (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 256.87M 724.90M 657.93M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
11.64M $ - 0.00% - -

more financials information »

Northwest Biotherapeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NWBO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.26690.380.26680.34950573,971,8380.0874532.77%
1 Month0.350.380.261050.33704812,523,1390.004351.24%
3 Months0.1720.4190.16510.32999282,740,4970.18235106.02%
6 Months0.1860.4190.140.26521532,254,7650.1683590.51%
1 Year0.2350.4190.140.25261471,718,3540.1193550.79%
3 Years0.24250.4190.140.24962361,530,6320.1118546.12%
5 Years0.52750.58590.140.2510731,563,836-0.17315-32.82%

Northwest Biotherapeutics (QB) Description

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.